Investing Ideas
/
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies

U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

213

13 new

Companies with a Value score of at least 3, ordered by Value score

213 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
0O1O Vetoquinol	€74.10	-5.2%	-27.5%	€879.2m	€96.31	PE18.6x	E8.9%	1.1%
0O9B Almirall	€7.95	-4.9%	-7.0%	€1.7b	€11.48	PS1.8x	E54.5%	2.3%
0J2O Halozyme Therapeutics	US$47.88	0.6%	28.9%	US$6.0b	US$65.25	PE15.2x	E21.1%	n/a
0K16 Evolus	US$10.74	-5.7%	8.2%	US$689.6m	US$23.10	PS2.8x	E74.0%	n/a
HIK Hikma Pharmaceuticals	UK£19.53	1.0%	10.2%	UK£4.3b	UK£23.65	PE19.1x	E12.2%	3.2%
0ILL Laboratorios Farmaceuticos Rovi	€61.40	-1.1%	2.9%	€3.1b	€92.01	PE19x	E18.5%	1.8%
HVO hVIVO	UK£0.20	-9.4%	-11.7%	UK£133.7m	UK£0.34	PE7.7x	E-29.6%	1.0%
HIKL Hikma Pharmaceuticals	UK£19.52	1.3%	9.8%	UK£4.3b	UK£23.66	PE19.1x	E12.2%	3.2%
0NM7 Virbac	€309.50	-4.2%	-13.4%	€2.6b	€402.94	PE18.4x	E10.8%	0.4%
0HB0 Agios Pharmaceuticals	US$35.64	-7.0%	51.2%	US$2.0b	US$57.64	PE3x	E-57.3%	n/a
0ND5 H. Lundbeck	DKK 40.07	-3.9%	24.1%	DKK 38.5b	DKK 49.84	PE14.9x	E8.8%	1.7%
0Y5E Perrigo	US$25.83	-5.5%	-18.5%	US$3.5b	US$35.90	PS0.8x	E63.8%	4.3%
0NTI Gerresheimer	€66.24	-12.9%	-30.4%	€2.3b	€110.57	PE20.4x	E21.8%	1.8%
C4XD C4X Discovery Holdings	UK£0.12	45.9%	-16.4%	UK£30.3m	UK£0.48	PE2.9x	E-88.3%	n/a
1SXPD SCHOTT Pharma KGaA	€25.68	0%	n/a	€3.6b	€34.87	PE24.2x	E15.7%	0.7%
NOVNz Novartis	CHF 86.93	-0.7%	2.6%	CHF 173.4b	CHF 103.11	PE16.5x	E7.0%	3.7%
COPNZ Cosmo Pharmaceuticals	CHF 59.10	-2.0%	14.8%	CHF 957.9m	CHF 96.32	PE14.8x	E17.2%	3.1%
0K6R Neurocrine Biosciences	US$136.71	8.4%	6.0%	US$13.7b	US$166.61	PE35.5x	E30.4%	n/a
0QLR Novartis	CHF 86.31	-1.6%	1.7%	CHF 173.4b	CHF 102.38	PE16.5x	E7.0%	3.7%
0QCO Pharming Group	€0.87	0.7%	-16.6%	€597.3m	€1.81	PS2.2x	E72.1%	n/a
0A5V Viatris	US$12.40	-1.2%	17.1%	US$14.9b	US$13.32	PS1x	E51.6%	3.8%
0TDF Roche Holding	US$34.40	-2.4%	-2.2%	US$198.6b	US$42.18	PE18.6x	E11.5%	3.9%
SDZZ Sandoz Group	CHF 37.14	0.05%	34.7%	CHF 16.3b	CHF 43.50	PS1.8x	E34.9%	1.2%
APH Alliance Pharma	UK£0.46	-4.4%	18.1%	UK£248.5m	UK£0.66	PS1.4x	E69.7%	0%

Page 1 of 9